Contract Manufacturing

Consider our plant and professionals like your own. With our expertise in bringing quality drugs to market quickly, Chartwell Pharmaceuticals is the ideal partner for contract manufacturing and packaging agreements. Our manufacturing facility has been in operation for over 20 years, and offers manufacturing capabilities including tablets, capsules, powders, suspensions and liquids. Custom packaging options include bottles in sizes from 20ct to 2000ct, enemas, and unit dose in both blisters and liquid cups.

Worried about import alerts or potential quality issues from working with overseas CMOs? With Chartwell, those concerns are a non-issue. Our manufacturing operations are proudly based in the USA and we boast a spotless most recent FDA inspection for which no Form 483 was issued, so you can rest easy.

Our partners can have it all: speed, quality, and quantity. That’s the advantage of engaging an experienced contract manufacturer with a creative approach to the business. Plus, we’re privately held-meaning you’re our priority, not stockholders or the market.

FACILITIES

Chartwell Pharmaceuticals LLC., operates a pristine manufacturing facility in Congers, New York. Facility expansion beginning in 2019 will allow for additional manufacturing, packaging, lab and warehouse space as well as add to our manufacturing capabilities and triple our production volume. We are also in the process of acquiring additional facilities and equipment. Together, the expansion and acquisition will greatly diversify and increase our dosage form and manufacturing capabilities.

The Congers facility is fully-cGMP compliant and has been operational for over 20 years.ears.

FACILITIES

Chartwell Pharmaceuticals LLC., operates a pristine manufacturing facility in Congers, New York. Facility expansion beginning in 2019 will allow for additional manufacturing, packaging, lab and warehouse space as well as add to our manufacturing capabilities and triple our production volume. We are also in the process of acquiring additional facilities and equipment. Together, the expansion and acquisition will greatly diversify and increase our dosage form and manufacturing capabilities.

The Congers facility is fully-cGMP compliant and has been operational for over 20 years.ears.